Lupus treatment centers on controlling inflammation, preventing flares, and protecting organs from long-term damage. There is no cure, but most people with lupus can reach low disease activity or even remission with the right combination of medications and lifestyle adjustments. The specific mix depends on which parts of your body are affected and how severe your symptoms are.
Hydroxychloroquine: The Foundation
Nearly every person diagnosed with lupus is started on hydroxychloroquine. International guidelines from EULAR recommend it for all patients unless there’s a specific reason they can’t take it. The target dose is 5 mg per kilogram of body weight per day, and going above that threshold raises the risk of damage to the retina over time. Most people take either 200 mg or 400 mg daily.
Hydroxychloroquine works slowly, often taking weeks to months before its full effects are noticeable. It reduces flares, helps control joint pain and skin rashes, and lowers the risk of organ damage accumulating over years. Because it’s well tolerated and protective over the long term, it typically stays in the treatment plan even as other medications are added or removed. Regular eye exams are part of the deal, usually once a year, to catch any early retinal changes.
Managing Pain and Inflammation
For joint pain and mild inflammation, anti-inflammatory painkillers like ibuprofen or naproxen are commonly used alongside hydroxychloroquine. They can be effective for day-to-day aches, but they come with real trade-offs for people with lupus. These drugs can raise blood pressure, cause fluid retention, and impair kidney function. If you already have lupus-related kidney disease, they’re generally avoided altogether. There’s also an increased cardiovascular risk worth weighing, since lupus itself already raises your chances of heart attack and stroke.
Steroids: Powerful but Short-Term
When lupus flares, steroids like prednisone are often the fastest way to bring inflammation under control. For moderate to severe flares, doctors sometimes use high-dose intravenous pulses for one to three days before switching to oral doses. The key goal with steroids is getting off them as quickly as possible. Guidelines recommend tapering to 5 mg per day or less of prednisone, and ideally stopping altogether, because long-term steroid use causes bone thinning, weight gain, high blood sugar, and a host of other problems that compound over years.
This push to minimize steroids drives much of the broader treatment strategy. When hydroxychloroquine alone isn’t enough to keep disease activity low enough to taper steroids, the next step is adding a steroid-sparing medication.
Immunosuppressants for Moderate Disease
If hydroxychloroquine and low-dose steroids aren’t controlling your symptoms, the next layer includes immunosuppressive medications like methotrexate, azathioprine, or mycophenolate. These drugs dial down the overactive immune response driving lupus.
Methotrexate, typically taken once a week, is often chosen for skin and joint symptoms. In one study of patients with moderate lupus, disease activity scores dropped from an average of 12.2 to 4.0 over six months, while daily steroid doses were cut roughly in half. Azathioprine serves a similar steroid-sparing role and is sometimes preferred for people planning pregnancy, since it has a longer safety track record in that context. Mycophenolate tends to be reserved for more significant disease, particularly when the kidneys are involved.
All of these medications suppress your immune system to some degree, so regular blood work is necessary to monitor your white blood cell counts, liver function, and kidney health. You’ll also be more susceptible to infections, which means staying current on vaccinations matters.
Biologic Therapies
Two biologic medications are now approved specifically for lupus, and both represent a significant shift in how moderate-to-severe disease is managed. They work through different pathways, so the choice between them depends on your specific disease pattern.
Belimumab targets a protein that helps certain immune cells survive and produce the antibodies that attack your own tissues. It tends to work best in people with high disease activity, low complement levels (a blood marker doctors track), and positive anti-dsDNA antibodies. It’s given as an injection or infusion and is used alongside standard therapy.
Anifrolumab blocks a different pathway, one involved in the body’s broad alarm system for danger and inflammation. It appears particularly effective for skin-dominant lupus and for patients whose blood tests show high activity in the interferon pathway, a pattern seen in a large proportion of people with lupus. Both biologics are added to existing treatment rather than replacing it.
When the Kidneys Are Involved
Lupus nephritis, where the immune system attacks the kidneys, is one of the most serious complications and requires more aggressive treatment. About half of all lupus patients develop some degree of kidney involvement during their lifetime.
The standard approach for active kidney disease uses mycophenolate or cyclophosphamide combined with steroids to induce remission, followed by a longer maintenance phase on mycophenolate at a lower dose. Newer combination strategies are changing this landscape. Adding belimumab to either of those regimens has shown additional benefit, and a newer drug called voclosporin, combined with mycophenolate, produced notably better results in clinical trials. In the AURORA 1 trial published in The Lancet, 41% of patients on voclosporin achieved a complete kidney response at one year compared to 23% on standard therapy alone.
Kidney involvement is monitored through urine tests checking for protein and blood, along with regular blood work measuring kidney function. Catching flares early and treating them aggressively makes a substantial difference in long-term kidney survival.
Severe or Refractory Cases
When lupus threatens major organs or doesn’t respond to the treatments above, stronger options come into play. Cyclophosphamide, a potent immunosuppressant given intravenously, is used for life-threatening disease involving the brain, lungs, or kidneys. For cases that resist even cyclophosphamide, rituximab (which depletes a specific type of immune cell) may be considered. These treatments carry more significant side effects, including a higher infection risk and potential impact on fertility, so they’re reserved for situations where the benefit clearly outweighs the risk.
What Remission Looks Like
The treatment goal is remission or, when that’s not achievable, a state of low disease activity. Remission in lupus doesn’t mean being off all medication. Under the internationally accepted DORIS criteria, remission means having no clinical disease activity and a very low physician assessment score, while still taking hydroxychloroquine and potentially a low dose of steroids (5 mg or less of prednisone) or a stable immunosuppressive. This definition reflects the reality that most people with lupus stay on some form of treatment long-term to prevent flares, even when they feel well.
Protecting Yourself From Flares
Ultraviolet light is one of the most reliable triggers for lupus flares, and sun protection is a non-negotiable part of managing the disease. The Lupus Foundation of America recommends sunscreen rated SPF 30 or higher with broad-spectrum protection against both UVA and UVB rays, reapplied every two hours and more frequently if you’re swimming or sweating. Tightly woven clothing that covers your arms and legs, wide-brimmed hats, and sunglasses add important layers of defense.
UV exposure isn’t limited to being outdoors. Fluorescent and halogen bulbs emit UV radiation that can trigger symptoms. Covering these bulbs with UV-filtering shields, using low-irradiance light bulbs at home, installing UV-blocking window shades, and tinting car windows all reduce your daily exposure. These steps may sound excessive, but for many people with lupus, they’re the difference between stable disease and a flare that requires weeks of increased medication to control.
Beyond UV avoidance, the broader lifestyle picture matters. Consistent sleep, stress management, and regular exercise (adjusted for joint symptoms) all contribute to keeping disease activity low. Smoking worsens lupus outcomes and interferes with hydroxychloroquine’s effectiveness, making quitting one of the highest-impact changes you can make.